A.Contingent Liabilities not provided       31-3-2011      31-3-2010 
 for in respect of                                 Rs.             Rs.
 
 1.Sales tax:
   Demands under contest(Net of Tax)          401,459         396,815
   C-Form Pending                           1,144,652         544,000
 
 2.Disputed Liquidated Damages with         1,232,982         422,813 
 respect to institutional customers
 (Net of Tax) 
 
 3.Excise Demand under dispute                 Nil             83,280
 
 4.Claims against the Company not           6,196,668       6,205,418 
 acknowledged as Debts 
 
 5.On account of guarantees given          29,728,407      31,933,107 
 by the bank on behalf of the 
 company in favor of customs and 
 others.
 
 6.The Company has imported capital           438,656         297,699
 goods under the Export Promotion
 Capital Goods Scheme  of the 
 Government of India at
 concessional rates of customs duty
 by undertaking obligations to export, 
 Future outstanding export obligations 
 under the Scheme as on 31-03-2011 
 aggregating of US$ 91582 if not 
 fulfilled may result in custom
 duty liability of (Net of tax)
 
 7.The Company has imported material          919,218      11,656,611
 under the Advance Authorization
 Scheme of the Government of India, at 
 concessional rates of customs duty by
 undertaking  obligations to export 
 certain quantity of specified 
 products, For the future outstanding 
 export obligations quantity under the 
 Scheme as at 31-03-2011, which if not 
 fulfilled may result in custom duty 
 liability of (Net of tax)
 
 C.  Employee Benefits
 
 Disclosures pursuant to Accounting Standard - 15 (Revised)'' Employee
 Benefits'':
 
 Defined Benefit Plan
 
 The Employees'' Group Gratuity Fund is the Company''s defined benefits
 plan for which Company has taken Group Gratuity cum Life Insurance
 Policy from Life Insurance Corporation of India. The present value of
 obligation is determined based on actuarial valuation using the
 Projected Unit Credit Method which recognizes each period of service as
 giving rise to additional unit of employee benefit entitlement and
 measures each unit separately to build up the final obligation.
 
 v) Investment Details
 
 The company has contracted with Life Insurance Corporation of India
 (LIC) to manage gratuity liability of the company.  The Company makes
 the required contribution to LIC based on computation of current
 service cost, expected earnings and actuarial assumptions etc. The
 Company has not made any other investment for defined benefit plan.
 
 F.  Expenditure on Research and Development
 
 Research and development expenditure of Rs. 19,230,425 is recognized as
 revenue expenses during the year.(Previous year Rs.20,236,200)
 
 G.  Increase in Equity Share Capital
 
 During the year, 165,250 equity shares each of Rs. 10 were issued on a
 preferential basis by the company at a premium of Rs. 29.97 each
 aggregating to Rs. 6,605,042/-. Further 3,638,000 equity shares of Rs
 10 were issued as bonus shares in ratio of 1:1 by capitalizing share
 premium which in aggregate amounts to Rs 36,380,000.
 
 H. Lease
 
 i) The Company does not have financial lease arrangement.
 
 I. Segment reporting
 
 The company operates in a single segment- Diagnostic Products.
 
 J. Related party disclosures
 
 Related party Disclosures as required by AS-18 are given below.
 
 1 Relationship.
 
 (i) Other Related parties where common control exists.  
 
      Span Biotherapeutics Pvt Ltd (Subsidiary) 
      Span Biotronics Pvt. Ltd.(Subsidiary) 
      Span Nihon Kohden Diagnostics Pvt. Ltd. (Joint Venture)
 
 (ii) Key Management Personnel: 
 
      Dr. Pradip K.Desai 
      Mr. VeeralP Desai
      Ms.SujataV. Desai 
      Dr. Madhukanta T. Patel
 
 (iii) Relatives of key management personnel and their enterprise, where
       transactions have taken place.  
 
     Ms. Lata P. Desai 
     Ms. Tejal V. Desai
     Ms.Shital S.Kazi 
     Mr. Prakash K. Desai 
     Shri. Pradip. K. Desai HUF 
     Dr.Harshad R. Gandhi 
     Ms. Kokila H. Gandhi 
     Mr. SunilT. Patel 
     Ms. Bhanuben T. Patel 
     Ms. Sudhaben I. Patel
 
 (iv) Enterprise over which persons described in (ii). (iii) above is
      able to exercise significant influence.  
 
    Span Diagnostics SARL 
    Quest Biochemicals Pvt. Ltd
 
 Note: Related party relationship on the basis of the requirements of
 Accounting Standard (AS) 18 as in 1 (i) to (iv) above is identified and
 certified by the Management and relied upon by the Auditors.
 
 
 
 Disclosure in Respect of Material Related Party Transactions during the
 year:
 
 1.  Sales of goods and material includes Span Diagnostic FZC Rs NIL
 (Previous Year Rs. 1,741,356), Span Nihon-Kohden Diagnostics Pvt. Ltd.
 Rs. NIL (Previous Year Rs. 403,419), Span Diagnostics SARLRs. 881,575
 (Previous Year NIL).
 
 2.  Purchases/material consumed from Span Nihon-Kohden Diagnostics Pvt.
 Ltd. Rs. 59,475,754 (Previous Year Rs.44,555,825), Span Diagnostics
 SARL Rs. 189,745 (Previous Year NIL)
 
 3.  Payment to Key Management Personnel include to Dr. Pradip K. Desai
 Rs. 6,830,600 (Previous Year 7,220,600), Mr. Veeral P. Desai Rs.
 4,403,800 (Previous Year Rs. 4,477,550 ), Dr. Madhukanta T. Patel Rs.
 2,356,567 (Previous Year Rs.1,883,600), Ms. SujataV. Desai Rs.
 2,319,950 (Precious Year Rs.1,971,888)
 
 4.  Interest on F.D./Loan includes Dr. Madhukanta T. Patel Rs. 228,048
 (Previous Year Rs.92,064), Ms.Sujata V. Desai Rs.  6,419 (Previous Year
 Rs. 11,109), Dr. Pradip K. Desai Rs. NIL (Previous Year Rs.75,455), Mr.
 Veeral P. Desai Rs. NIL (Previous Year Rs.21,528), Ms. Lata P. Desai
 NIL (Previous Year Rs. 9,615), Ms. Shital S. Kazi Rs. NIL (Previous
 Year Rs.68,356), Ms. Tejal V. Desai Rs. 3,315 (Previous Year Rs.
 205,745), Shri Pradip K. Desai (HUF) Rs. NIL (Previous Year Rs.
 44,267), Dr. Harshad R. Gandhi Rs. 77,927 (Previous Year Rs. 75,214),
 Ms. Kokila H. Gnadhi Rs. 116,427 (Previous Year Rs. 112,794), Mr.
 SunilT. Patel Rs. 32,058 (Previous Year Rs. 31,902)
 
 5.  Rent paid to Mr. Veeral P. Desai Rs. 24,000 (Previous Year Rs.
 22,000), Ms. Bhanuben T. Patel Rs. 60,000 (Previous Year Rs. 60,000),
 Ms.Sudhaben I. Patel Rs. 112,000 (Previous Year Rs. NIL)
 
 6.  Dividend Paid to Dr. Pradip K. Desai Rs. 651,975 (Previous Year Rs.
 NIL), Mr. Veeral P. Desai Rs. 655,790 (Previous Year Rs. NIL), Dr.
 Madhukanta T. Patel Rs. 69,950 (Previous Year Rs. NIL), Ms. Sujata V.
 Desai Rs. 126,970 (Previous Year Rs.  NIL), Ms. Lata P. Desai Rs.
 896,325 (Previous Year Rs. NIL), Ms. Shital S. Kazi Rs. 49375 (Previous
 Year Rs.NIL), Ms.Tejal V. Desai Rs.12,500 (Previous Year Rs. NIL), Mr.
 Prakash K. Desai Rs. 33,750 (Previous Year Rs. NIL), Shri Pradip K.
 Desai (HUF) Rs. 981,625 (Previous Year Rs. NIL), Mr. Sunil T. Patel Rs.
 12,500 (Previous Year Rs. NIL), Ms. Sudhaben I. Patel Rs.12,500
 (Previous Year Rs. NIL)
 
 7.  R&D Outsourcing Charges paid to Span Biotronics Pvt. Ltd. Rs.
 9,140,000 (Previous Year Rs. 7,100,000)
 
 8.  Gardening Expense paid to Desai Agri Biotech Rs. 611,797 (Previous
 Year Rs. 611,362)
 
 9.  Sales and Distribution Expenses include to Span Diagnostics FZC Rs.
 NIL (Previous Year Rs. 1,007,203)
 
 10.  Royaltypaidto Span Diagnostics SARLRs. 1,154,651 (Previous Year
 Rs.NIL)
 
 11.  License Fees from Span Nihon-Kohden Pvt. Ltd. Rs.2,190,000
 (Previous Year Rs.21,90,000)
 
 12.  Other Income from Span Diagnostics SARL Rs. NIL (Previous Year
 Rs.668,300), Span Diagnostics FZC Rs. NIL (Previous Year Rs.18,016)
 
 13.  Loan received in the nature of fixed deposit from Span
 Nihon-Kohden Pvt. Ltd. Rs. NIL (Previous Year Rs.3,000,000), Dr.
 Madhukanta T. Patel Rs. 800,000 (Previous Year Rs. NIL), Ms. Sujata V.
 Desai Rs. 100,000 (Previous Year Rs. NIL), Ms. Tejal V. Desai Rs.
 250,000 (Previous Year Rs. NIL), Dr. Harshad R. Gnadhi Rs. NIL
 (Previous Year Rs.150,000), Ms.  Kokila H. Gandhi Rs. NIL (Previous
 Year Rs. 200,000)
 
 14.  Loan & Advances in nature of expense reimbursement given during
 the year include Span Nihon-Kohden Pvt. Ltd.  Rs.106,465 (Previous Year
 Rs.1,036,551), Span Biotherapeutics Pvt. Ltd. Rs. 6,038 (Previous Year
 Rs. NIL), Span Diagnostics SARL Rs. NIL (Previous Year Rs. 209,250),
 Span Biotronics Pvt. Ltd. Rs. 4,144 (Previous Rs. 100)
 
 15.  Purchase of Technology include Span Daignostics SARLRs.
 NIL(PreviousYearRs. 2,961,198)
 
 16.  Purchase of Fixed Assets include Span Daignostics SARL Rs. NIL
 (Previous Year Rs. 941,695)
 
 17.  Purchase of Investment include Span Biotherapeutics Pvt. Ltd. Rs.
 99,900 (Previous Year Rs. NIL)
 
 18.  Loss on Sale of Investment Include Span Diagnostics FZC Rs. NIL
 (Previous Year Rs. 756,821)
 
 
 K.  Disclosure of Loans and Advances to Subsidiaries. Associates. Joint
 Ventures and Others (Pursuant to Clause 32 of the Listing Agreement):
 
 During the year the Company has not entered into any transaction in
 nature of loans and advances which falls within the purview of clause
 32 of the listing agreement
 
 
 P.  Exchange Rate Difference
 
 The Exchange rate difference arising on foreign currency transactions
 has been credited to Profit and Loss account Rs. 787,520 (Profit)
 [Previous Year 6,151,205 (Profit)].
 
 Q.  Disclosure for Borrowing Cost Capitalized
 
 In accordance with AS-16 related to Borrowing cost which amounts to Rs.
 581,322 has been capitalized during the year (Previous Year Rs. 80,780)
 
 S. Balances of sundry debtors are as per books of accounts. During the
 year Company has written off debtors to tune of Rs 10,45,012 (Previous
 Year 1,657,456) against provision made in earlier years as are
 considered non-recoverable.
 
 T. The figures for the previous year have been
 regrouped/recast/reclassified wherever necessary in conformity with
 those of current year.
 
 d) Derivative contracts entered into by the Company and outstanding as
 on 31st March, 2011
 
 (i) For hedging interest rate related risks derivative contract in
 nature of forward contract is entered into by the Company and
 outstanding of which as on 31st March,2011amounttoRs 109,995,200 
 (ii) Foreign currency exposures that are not hedged by derivative
 instruments as on 31st March,2011 amount to
 Rs.18,550,313(net)
 
 h) Quantitative Details (Manufacturing)
 
 NOTES : 1.  Licenced Capacity : As per Industrial Enterpreneur
 Memorandum filed with Government of India. In respect of the products
 presently manufactured by the company.
 
 2.  Sales are shown after discount and sales return.
 3.  Materials produced for captive use excluded from sales.
 4.  Previous year figures are shown in brackets.
 5.  Annual Installed capacity being a techincal matter, it is as
 certified by the production manager and accepted by the auditors.